US$ 23.73
private digital health companies obesity management glp-1 Digbi Launches GLP-Fit™ Program: Expands its Precision Biology – Digbi Health Market Overview: GLP-1 Agonists and
Description
Please make sure that the shipping address is correct and available

Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults

This meta-analysis assesses the effects of GLP-1 RAs on body composition across various components, providing a comprehensive overview of the effects associated with different agents and their applications

doi: 10.1038/ejcn.2016.268
